论文部分内容阅读
目的观察低分子肝素联合贝那普利治疗儿童肾病综合征的临床效果。方法选取2008年12月至2011年3月在本院进行治疗的151例肾病综合征患儿为研究对象,采取前瞻性随机对照法分为实验组(低分子肝素联合贝那普利方案组)82例和对照组(贝那普利组)69例,比较两种治疗方法的临床疗效。结果实验组患者经低分子肝素联合贝那普利方案治疗后,总有效率为98.78%,明显高于对照组,P<0.05。结论低分子肝素联合贝那普利方案治疗儿童肾病综合征的临床效果良好,可以在临床推广。
Objective To observe the clinical effect of low molecular weight heparin combined with benazepril on children with nephrotic syndrome. Methods 151 children with nephrotic syndrome treated in our hospital from December 2008 to March 2011 were selected as prospective randomized controlled trial and divided into experimental group (low molecular weight heparin plus benazepril group) 82 cases and control group (benazepril group), 69 cases, the clinical efficacy of the two treatment methods were compared. Results After treatment with low molecular weight heparin and benazepril, the total effective rate was 98.78% in the experimental group, which was significantly higher than that in the control group (P <0.05). Conclusion Low molecular weight heparin combined with benazepril treatment of children with nephrotic syndrome clinical effect is good and can be clinically promoted.